Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
David Arkowitz | Chief Financial Officer | $1.88M | May 10, 2021 | ||
Samuel D. Colella | Director | Nov 19, 2021 | |||
Heath Lukatch | Director | Nov 19, 2021 | |||
Mark S. Levine | General Counsel | Nov 19, 2021 | |||
Christina Willwerth | Chief Strategy Officer | Nov 19, 2021 | |||
Melissa Layman | Chief Commercial Officer | Nov 19, 2021 | |||
Patrick Mahaffy | Director | Nov 19, 2021 | |||
Scott A. Canute | Director | Nov 19, 2021 | |||
C. Ann Merrifield | Director | Nov 19, 2021 | |||
Mark Stejbach | Director | Nov 19, 2021 | |||
William T. Andrews | Chief Medical Officer | Nov 19, 2021 | |||
Utpal Koppikar | Director | Nov 19, 2021 | |||
Michael D. Clayman | President and CEO, Director | Nov 19, 2021 | |||
Adam Muzikant | Chief Business Officer | Nov 19, 2021 | |||
Elizabeth Kwo | Director | Nov 19, 2021 | |||
Alan Milinazzo | Director | Nov 19, 2021 | |||
Kerry Wentworth | Chief Regulatory Officer | Nov 19, 2021 | |||
Frederick Driscoll | Chief Financial Officer | Nov 19, 2021 | |||
Newtyn Management, LLC | 10%+ Owner | Nov 19, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|